Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and...
FDA Recall #D-0355-2026 — Class II — January 29, 2026
Product Description
Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC: 45963-676-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054
Reason for Recall
Failed Dissolution Specifications
Recalling Firm
Teva Pharmaceuticals USA, Inc — Parsippany, NJ
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
67,043 bottles
Distribution
Nationwide
Code Information
Lot#: a) 0486G251, 0487G251, 0488G251, Exp.: 01/2027; b) 0486G252, 0487G253, 0488G252, Exp.: 01/2027.
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated